Tech Company Financing Transactions
AGTC Funding Round
AGTC closed a $9.6 million investment round on 6/30/2013. Investors included Alta Partners, Intersouth Partners and private investors.
Transaction Overview
Company Name
Announced On
6/30/2013
Transaction Type
Venture Equity
Amount
$9,621,000
Round
Undisclosed
Investors
Intersouth Partners (James Rosen)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
14193 NW 119th Ter. 10
Alachua, FL 32615
USA
Alachua, FL 32615
USA
Phone
Website
Email Address
Overview
AGTC is developing cures for rare lung and eye diseases, offering hope to patients with unmet medical needs.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sue Washer
Chief Financial Officer
William Sullivan
Chief Medical Officer
Theresa Heah
Chief Scientific Officer
Mark Shearman
VP - Bus. Development
Matthew Feinsod
VP - Bus. Development
Stephen Potter
VP - General Counsel
Brian Krex
Browse more venture capital transactions:
Prev: 6/30/2013: Enumeral Biomedical venture capital transaction
Next: 6/30/2013: Neurovance venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC transactions reported here are sourced from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs